SCHEMBL5390989

SCHEMBL5390989

COc1ccccc1C(=O)Nc1ccc(O)cc1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.71
RAB9A P51151 4/20 0.71
ALDH1A1 P00352 3/20 0.71
KCNK3 O14649 1/20 0.69
KCNK9 Q9NPC2 1/20 0.69
KMT2A Q03164 4/20 0.69
NPC1 O15118 3/20 0.69
MEN1 O00255 1/20 0.69
POLB P06746 1/20 0.69
SMN1; SMN2 Q16637 4/20 0.68
LMNA P02545 3/20 0.68
MAPK1 P28482 3/20 0.68
TP53 P04637 2/20 0.68
KDM4E B2RXH2 1/20 0.68
GFER P55789 3/20 0.65
GAA P10253 2/20 0.65
HSD17B10 Q99714 2/20 0.65
TSHR P16473 1/20 0.63
AHR P35869 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2721612 0.89 MAPT (0.73) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL2362772 0.88 KMT2A (0.82) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL30739719 0.87 MAPT (0.71) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL3949532 0.87 KMT2A (0.78) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL4429130 0.87 MAPT (0.71) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL94630 0.86 MAPT (0.69) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL6294966 0.86 PNLIP (0.70) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL4429129 0.86 MAPT (0.69) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL4432153 0.86 MAPT (0.69) MAPTRAB9AALDH1A1KCNK3KCNK9
SCHEMBL678394 0.86 MAPT (0.69) MAPTRAB9AALDH1A1KCNK3KCNK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors ELI LILLY AND COMPANY 2005-01-27 US disclosed
EP-1392637-A2 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS ELI LILLY AND COMPANY (US) 2004-03-03 EP disclosed
WO-2002100813-A2 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS ELI LILLY AND COMPANY (US) 2002-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors NCOA4, PPARG, PPARA MAPT 4740/4885RAB9A 3987/4885ALDH1A1 2292/4885
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors PPARG, NCOA4, PPARA MAPT 4674/4885RAB9A 3865/4885ALDH1A1 2029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.